Introduction

Neurofibromatosis refers to a group of genetic disorders which all have common occurrences of tumours of the nerve sheath.¹ These develop in areas such as the brain, spinal cord, organs, skin and bones.² There are three main types that are referred to as Neurofibromatosis, Neurofibromatosis Type 1 or 2. NF1 is the most common and accounts for around 96% of all neurofibromatosis. It is known by its peripheral nerve tumours that lead to skin changes and the deformation of bone. These tumours tend to originate from Schwann cells. The other types of neurofibromatosis account for less than 4% of cases combined, hence a much rarer variant. NF2 is known for causing hearing loss and vestibular dysfunction, whereas the other type causes severe pain. Regarding the eye effects, type 1 will be the one that influences the optic nerves, as the tumours develop on the peripheral nervous system. It is important to understand how neurofibromatosis affects the eye, as depending on the positioning of developing tumours, eyesight and general eye health may be significantly affected. As the tumours develop in random areas, each case is different and will affect the quality of life of each patient differently. Many neurofibromatosis cases lead to tumour development around the eye as well as on the eyelid itself, and further in this article, I will talk about the effects of each. However, in general, neurofibromatosis and its consequent eye problems are somewhat under-researched in comparison to other problems it causes; however, the data currently available can provide a good basic understanding of its effect on the eyes.

The diagnosis is a crucial part of understanding the development of optic problems in those with neurofibromatosis and the first part of the problem. It is essential to have regular ophthalmological tests to be able to identify any abnormalities and further manage complications (Listernick et al., 2007). The tests that will be conducted are usually visual field assessments, visual acuity tests and fundoscopic examinations to identify any optic nerve anomalies or Lisch nodules, which indicate neurofibromatosis tumour damage (Brewer et al., 2022). A further method used to diagnose optic dysfunction is through optical coherence tomography, which analyses the retinal nerve fibre layer thickness and helps to identify any early indications of pathway gliomas (Avery et al.,2015). To help further confirm the presence of these tumours, Magnetic Resonance Imaging may be used to help understand the optic pathways that the tumour affects and to help monitor the progression. It is recommended that children who have NF1 have annual check-ups till they reach 8 years of age, in which check-ups should be conducted every 2 to 3 years (Hirbe & Guttmann, 2014). It has also been found that genetic testing can confirm NF diagnoses and also be used to predict the chances of any other optical complications developing in the future.

Both Neurofibromatosis type 1 (NF1) and type 2 (NF2) can lead to significant ocular complications, though their manifestations differ. Let's explore the eye problems associated with each type, keeping in mind that every patient's experience is unique.

Neurofibromatosis type 1 (NF1)

NF1, also known as von Recklinghausen's disease, is the more common form of neurofibromatosis. It affects about 1 in 3,000 people worldwide (Ferner et al., 2007). For those living with NF1, eye problems can be a significant concern.

One of the most distinctive ocular features of NF1 is Lisch nodules. These small, dome-shaped growths on the iris are harmless but can be a telltale sign of the condition. They're often described as looking like "freckles" on the colored part of the eye. While they don't usually affect vision, their presence can help diagnose NF1, especially in children (Listernick et al., 2007).

A more serious ocular complication of NF1 is the development of optic pathway gliomas. These are tumours that grow along the optic nerve or chiasm. They occur in about 15-20% of children with NF1 (Avery et al., 2015). The tricky part is that these tumors can be sneaky - they don't always cause noticeable symptoms right away. When they do, it might manifest as vision loss, squinting, or bulging of the eye. That's why regular eye check-ups are so crucial for people with NF1, especially children.

Other eye problems associated with NF1 include:

1. Glaucoma: Increased pressure in the eye that can damage the optic nerve.
2. Retinal abnormalities: Changes in the light-sensitive tissue at the back of the eye.
3. Orbital neurofibromas: Benign tumors that can affect eye movement or cause the eye to protrude.

Neurofibromatosis type 2 (NF2)

NF2 is less common than NF1, affecting about 1 in 25,000 to 40,000 people (Evans, 2009). While it shares the same name, NF2 is quite different from NF1, including its ocular manifestations.

The hallmark of NF2 is the development of vestibular schwannomas, tumours that grow on the nerves responsible for balance and hearing. But NF2 can affect the eyes too, often in ways that are more subtle than NF1.

One of the most common eye problems in NF2 is the development of cataracts. These are cloudy areas in the lens of the eye that can blur vision. What's interesting is that the cataracts in NF2 often have a distinctive appearance, described as "Christmas tree" or "posterior subcapsular" cataracts (Parry et al., 1994). They can develop at a much younger age than typical age-related cataracts, sometimes even in childhood.

Another significant ocular issue in NF2 is the development of retinal hamartomas. These are benign tumours of the retina that can cause vision problems if they grow large enough or are located in a critical area. They're found in about 20% of people with NF2 (Bosch et al., 2006).

Less common but potentially serious eye problems in NF2 include:

1. Optic nerve sheath meningiomas: Tumours that grow around the optic nerve
2. Epiretinal membranes: A thin layer of scar tissue that forms on the retina's surface
3. Strabismus: Misalignment of the eyes, which can occur due to tumours affecting the nerves controlling eye movement

Living with the ocular complications of NF1 or NF2 can be challenging. It's not just about the physical symptoms - there's an emotional toll too. The uncertainty of potential vision loss or the need for multiple surgeries can be stressful. However, with regular monitoring and advances in treatment, many people with NF1 and NF2 maintain good vision throughout their lives.

For both NF1 and NF2, early detection and regular follow-ups are key. Experts recommend annual eye exams for children with NF1 until age 8, then every 2-3 years after that (Hirbe & Gutmann, 2014). For NF2, annual eye exams are typically recommended throughout life. Treatment strategies vary depending on the specific eye problem and its severity. For NF1 patients with optic pathway gliomas, options range from watchful waiting to chemotherapy or surgery. The goal is always to treat the tumour while preserving as much vision as possible. It's a delicate balance that requires expert care.

For NF2 patients dealing with cataracts, there's good news. A straightforward surgery to replace the cloudy lens with an artificial one can significantly improve vision. Cataract surgery removes a cloudy lens and replaces it with a clear artificial one. The surgeon makes a small incision, breaks up the lens using ultrasound, removes the fragments, and inserts an artificial lens. The quick procedure typically takes 15-20 minutes per eye, with patients often experiencing improved vision within days. While we can't prevent NF itself, we can take steps to minimise eye complications. Protecting eyes from UV radiation, maintaining a healthy diet rich in eye-friendly nutrients, and avoiding smoking all contribute to better eye health. These are good habits for everyone, not just those with NF. Emerging treatments offer new hope, too. Recent research into MEK inhibitors has shown promise in shrinking optic pathway gliomas in some NF1 patients. This development could potentially change how we manage certain NF-related eye problems in the future.

It's important to remember that dealing with NF and its associated eye problems isn't just about medical treatment. The emotional toll can be significant. That's why psychological support and patient education are crucial parts of comprehensive care. Connecting with support groups or counsellors can make a world of difference in coping with the uncertainties of NF.

In conclusion, neurofibromatosis presents significant challenges to eye health, particularly in NF1 and NF2. The key to managing these complications lies in early detection, regular monitoring, and tailored treatment approaches. While NF1 often affects the optic nerves and can cause optic pathway gliomas, NF2 is associated with cataracts and retinal hamartomas. Advances in diagnostic techniques and treatments, including cataract surgery and promising research on MEK inhibitors, offer hope for improved outcomes. However, the impact of NF on vision extends beyond physical symptoms, emphasising the need for comprehensive care that includes psychological support. With ongoing research and a multidisciplinary approach, the outlook for managing NF-related eye problems continues to improve, offering patients a better quality of life.

Summary

Neurofibromatosis (NF) is a group of genetic disorders that cause nerve sheath tumours and can significantly affect the eyes, particularly in NF1 and NF2.

• NF1 (most common, ~96% of cases): Key ocular signs include harmless Lisch nodules on the iris and more serious optic pathway gliomas (15–20% of children), which can lead to vision loss. Other complications include glaucoma, retinal changes, and orbital neurofibromas
• NF2 (rare): Commonly associated with early cataracts (often “Christmas tree” type) and retinal hamartomas. Less frequent issues include optic nerve sheath meningiomas, epiretinal membranes, and strabismus
• Diagnosis & Monitoring: Regular ophthalmic exams, imaging (MRI, OCT), and genetic testing are vital. Children with NF1 need annual exams until age 8, then every 2–3 years; NF2 patients require lifelong annual exams
• Treatment: Ranges from observation to chemotherapy or surgery for optic gliomas in NF1, while cataracts in NF2 are effectively managed with surgery. Emerging treatments like MEK inhibitors show promise for NF1-related gliomas
• Holistic Care: Beyond physical symptoms, NF eye complications can cause psychological stress, making counselling and support groups important

Key Point: Early detection, regular monitoring, and individualised treatment are essential to preserve vision and improve the quality of life for patients with NF1 and NF2.